Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-19T09:07:43.805Z Has data issue: false hasContentIssue false

Free Fatty Acids and Stroke From Atrial Fibrillation

Published online by Cambridge University Press:  02 December 2014

J. David Spence*
Affiliation:
Stroke Prevention & Atherosclerosis Research Centre, Robarts Research Institute, University of Western Ontario London, Ontario, Canada
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Copyright
Copyright © The Canadian Journal of Neurological 2011

References

1.Seo, W-K, Kim, J, Kim, YH, et al.Elevated free fatty acid is associated with cardioembolic stroke subtype. Can J Neurol Sci. 2011; 38(6):8749.Google Scholar
2.Schurks, M, Glynn, RJ, Rist, PM, et al.Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ. 2010;341:c5702.Google Scholar
3.Soardo, G, Donnini, D, Domenis, L, et al. Oxidative stress is activated by free fatty acids in cultured human hepatocytes. Metab Syndr Relat Disord. 2011;ePub ahead of print May 11, 2011.Google Scholar
4.Pilgeram, L.Control of fibrinogen biosynthesis: role of the FFA/albumin ratio. Cardiovasc Eng. 2010;10:7883.Google Scholar
5.Mutanen, M, Freese, R.Fats, lipids and blood coagulation. Curr Opin Lipidol. 2001;12:259.Google Scholar
6.Miller, GJ, Martin, JC, Webster, J, et al.Association between dietary fat intake and plasma factor VII coagulant activity-a predictor of cardiovascular mortality. Atherosclerosis. 1986;60:26977.Google Scholar
7.Rigla, M, Wagner, AM, Borrell, M, et al.Postprandial thrombin activatable fibrinolysis inhibitor and markers of endothelial dysfunction in type 2 diabetic patients. Metabolism. 2006;55:143742.Google Scholar
8.Nordoy, A, Bonaa, KH, Sandset, PM, et al.Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia. Arterioscler Thromb Vasc Biol. 2000;20:25965.Google Scholar
9.Poli, D, Antonucci, E, Cecchi, E, et al.Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation: the role of homocysteine. Stroke. 2005;36:215963.Google Scholar
10.Spence, JD.Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurol. 2007;7:8308.Google Scholar
11.Mozaffarian, D, Katan, MB, Ascherio, A, et al.Trans fatty acids and cardiovascular disease. N Engl J Med. 2006;354:160113.CrossRefGoogle ScholarPubMed
12.Spence, JD, Jenkins, DJ, Davignon, J.Dietary cholesterol and egg yolks: not for patients at risk of vascular disease. Can J Cardiol. 2010;26:e336e9.Google Scholar
13.Spence, JD.Secondary stroke prevention. Nat Rev Neurol. 2010;6:47786.Google Scholar